John G Ullman & Associates Inc United Therapeutics Corp Transaction History
John G Ullman & Associates Inc
- $624 Million
- Q2 2025
A detailed history of John G Ullman & Associates Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, John G Ullman & Associates Inc holds 7,281 shares of UTHR stock, worth $2.05 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
7,281
Previous 7,356
1.02%
Holding current value
$2.05 Million
Previous $2.27 Million
7.72%
% of portfolio
0.34%
Previous 0.38%
Shares
10 transactions
Others Institutions Holding UTHR
# of Institutions
734Shares Held
43.1MCall Options Held
125KPut Options Held
124K-
Black Rock Inc. New York, NY5.47MShares$1.54 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.46MShares$1.26 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.68MShares$754 Million13.34% of portfolio
-
State Street Corp Boston, MA2.23MShares$629 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.11MShares$594 Million1.04% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $12.8B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...